Let’s be real: pitching is brutal. You pour your soul into a startup. It becomes your 4 AM wake-up call, your all-consuming obsession, the thing you love so much that when the time comes to sell it—really sell it—you choke. Not because you don’t believe in it, but because you believe too much.
As part of our quick founder questions series – or QFQs – we spoke to Andriy Dovbenko, Founder and Principal of UK-Ukraine TechExchange about how necessity leads to technological innovation, strengthening commercial ties between the UK and Ukrainian defence sectors and the need to de-mine Ukraine.
Last month, I got a new job. Except this didn’t come with the standard trappings of a fresh role - no new colleagues, changed commute, nor complicated coffee machine to contend with. Instead, I was taking on a new position in the organisation I co-founded and have helped lead for nearly a decade.
In a turbulent economic landscape for startups, building trust is more important than ever. What is AI sovereignty and how can it help? Maddyness UK investigates.
HMRC’s R&D relief scheme exists to support fast-growing tech businesses, promote innovation among them, and ultimately make a significant contribution to the UK economy and GDP. However, the process has become more complex over time, with HMRC bringing in increasingly stringent rules and regulations to ensure the scheme is used correctly.
Recent reports suggest that generative AI alone could add between €1.2T and €1.4T to the European Union's GDP over the next decade. As Europe seeks to capitalise on this technological revolution, the question is not just about embracing AI but strategically integrating it to unlock maximum value. In this article we look at which sectors stand to gain the most, and what strategies will ensure Europe realises this trillion-euro opportunity?
While women remain less visible in tech and AI than men, Maddyness has identified five female entrepreneurs to follow in the artificial intelligence sector.
On the back of the European announcement to invest heavily in its military arsenal, Maddyness has identified four French and European startups that are playing a role in the defence sector.
As GLP-1 medications like Ozempic and Mounjaro dominate headlines, a new weight-loss solution is emerging for the millions left without viable options. Oxford Medical Products (OMP) has announced further positive results from its three-month clinical trials for Sirona, a breakthrough treatment targeting those classified as overweight (BMI 25-30) and those transitioning off GLP-1 drugs.
As part of our quick founder questions series – or QFQs – we spoke to Chad Edwards, cofounder and CEO of CuspAI about investment, material science and using AI to deliver meaningful change.
With #QVCs, Maddyness UK profiles different funds to give founders and entrepreneurs the information they need to choose the right investor. This week, we speak to Johnathan Matlock, cofounder of Empirical Ventures.
Paris Saint-Germain (PSG) is setting its sights on innovation beyond football, launching PSG Labs, an accelerator designed to foster groundbreaking projects in the sports industry. This new initiative was unveiled at the Web Summit Qatar, and the first hub will be based in Doha, Qatar.
The Maddyness teams have been committed for over a decade to the most innovative companies in France and those closest to entrepreneurs. Every day, we are committed to promoting your operations, to creating the best content for you, in all its forms. Want to work with the favorite media of entrepreneurs? Us too.
Thank you to all our readers, it's thanks to your enthusiasm and interest that we are able to publish daily news about business, startups and the economy.
Your support is important to us, sign up to have exclusive access to VIP content.